(Q37610203)

21 August 2017

Cannabinoids for the treatment of multiple sclerosis: no smoke without fire? (English)

1 reference

21 August 2017

0 references

0 references

Paul F Smith

1

1 reference

21 August 2017

1 May 2003

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

21 August 2017

1 reference

21 August 2017

3

1 reference

21 August 2017

327-334

1 reference

21 August 2017

3

1 reference

Cannabinoid receptor localization in brain

21 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.3.327

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.3.327

The endocannabinoid system as a target for therapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.3.327

Cannabinoid receptors and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.3.327

Multiple sclerosis therapy. A practical guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.3.327

Tetrahydrocannabinol for tremor in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.3.327

Effect of cannabinoids on spasticity and ataxia in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.3.327

Control of pain initiation by endogenous cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.3.327

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.3.327

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.3.327

A community survey of adverse effects of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.3.327

Abstinence symptoms following oral THC administration to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.3.327

Abstinence symptoms following smoked marijuana in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.3.3.327

21 January 2018

Identifiers

DOI

10.1586/14737175.3.3.327

1 reference

21 August 2017

1 reference

PubMed ID

19810900